http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022105109-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24dccbc3d04ae6c70b3e5df398ea93bb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-616 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426 |
| filingDate | 2020-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f469aaee3635454e7c6fffd7f9064178 |
| publicationDate | 2022-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2022105109-A1 |
| titleOfInvention | Methods of treating covid-19 and compositions therefor |
| abstract | Methods and compositions for treating COVID-19 in humans, particularly for treating at least one respiratory symptom, are disclosed. The composition includes a therapeutically effective amount of acetylsalicylic acid (ASA), expected to be in the range of approximately 0.4-4.0 grams per day. The composition may also include a therapeutically effective amount of famotidine, expected to be in the range of approximately 10-160 milligrams per day. |
| priorityDate | 2020-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 100.